<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03632408</url>
  </required_header>
  <id_info>
    <org_study_id>T271</org_study_id>
    <nct_id>NCT03632408</nct_id>
  </id_info>
  <brief_title>Hangover and Residual Zopiclone Effect on Spatial Perception</brief_title>
  <acronym>SEKO-A</acronym>
  <official_title>The Effect of Alcohol Hangover and Night-time Zopiclone on Next-morning Spatial Perception in Healthy Young Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Petri Vainio</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Turku</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hangover after recreational alcohol use, residual effect of zopiclone and placebo compared in
      terms of spatial perception, psychomotor tests and simulated driving ability. Three recording
      visits plus screening included.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2018</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Alcohol not masked Zopiclone and placebo capsulated, identical in weight and appearance Third party generated code only available to pharmacy and in case of emergency</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Driving error rate</measure>
    <time_frame>Day 1</time_frame>
    <description>Driving error rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of erroneous responses to peripheral visual stimuli during driving</measure>
    <time_frame>Day 1</time_frame>
    <description>Number of erroneous responses to peripheral visual stimuli during driving</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>digit symbol substitution</measure>
    <time_frame>Day 1</time_frame>
    <description>digit symbol substitution test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>drug concentration</measure>
    <time_frame>Day 1</time_frame>
    <description>concentration of zopiclone in plasma</description>
  </secondary_outcome>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Healthy</condition>
  <condition>Alcohol Drinking</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Zopiclone</intervention_name>
    <description>Oral, single dose, 7.5 mg</description>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>hangover</intervention_name>
    <description>as per subjects choice to consume alcohol</description>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo oral capsule</intervention_name>
    <description>oral</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  weight &gt;45 kg

          -  likely to experience and predict alcohol hangover within the next five weeks

          -  no childbearing potential of negative pregnancy test at screening

          -  a valid driving license

        Exclusion Criteria:

          -  breastfeeding

          -  infection with HCV, HBV or HIV

          -  a medical or psychiatric condition or laboratory abnormality that may increase the
             risk associated with study participation

          -  suspected or current drug or alcohol abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Petri J Vainio, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Turku University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Petri J Vainio, MD</last_name>
    <phone>+358294504657</phone>
    <email>pejvai@utu.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Teutori clinical trial facility</name>
      <address>
        <city>Turku</city>
        <zip>20520</zip>
        <country>Finland</country>
      </address>
    </facility>
    <contact>
      <last_name>Petri J Vainio, MD</last_name>
      <phone>0294504657</phone>
      <email>pejvai@utu.fi</email>
    </contact>
    <investigator>
      <last_name>Petri J Vainio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 7, 2018</study_first_submitted>
  <study_first_submitted_qc>August 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2018</study_first_posted>
  <last_update_submitted>August 14, 2018</last_update_submitted>
  <last_update_submitted_qc>August 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Turku University Hospital</investigator_affiliation>
    <investigator_full_name>Petri Vainio</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcohol Drinking</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zopiclone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

